Recombinant Zoster Vaccine is named as a drug or biological intervention in 3 clinical trials in our China trial register, none of which are currently recruiting. Lead sponsors include MAXVAX Biotechnology Limited Liability Company (2) and Ab&B Bio-tech Co., Ltd.JS (1). Registered phases: Phase 3 and Phase 1/2. Conditions studied include Herpes Zoster; Herpes Zoster Vaccine.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06654700 | Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell). (ClinicalTrials.gov ↗) Herpes Zoster |
Phase 3 | Not yet open |
| NCT06447779 | Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older (ClinicalTrials.gov ↗) Herpes Zoster |
Phase 3 | Active, closed |
| NCT06851832 | Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older (ClinicalTrials.gov ↗) Herpes Zoster, Herpes Zoster Vaccine |
Phase 1/2 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Herpes Zoster | 3 |
| Herpes Zoster Vaccine | 1 |
| Lead sponsor | Trials |
|---|---|
| MAXVAX Biotechnology Limited Liability Company | 2 |
| Ab&B Bio-tech Co., Ltd.JS | 1 |
| Register | Recombinant Zoster Vaccine trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Recombinant Zoster Vaccine works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Recombinant Zoster Vaccine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.